AmerisourceBergen Acclimates to the New Normal

Chain Drug Review |

During these trying times, AmerisourceBergen Corp. continues to play a vital role feeding the health care supply chain and, through its global pharmaceutical health care businesses, helping combat the ongoing spread of ­COVID-19.

Rich Tremonte, executive vice president and president of community and specialty pharmacy at AmerisourceBergen, says that, like every industry, the pharmaceutical supply chain has had to adjust to these unprecedented circumstances. “We are proud of the resiliency of the supply chain and our collective efforts with manufacturers and suppliers to protect it. In March, when the coronavirus was declared a pandemic, we saw surge ordering across all classes of trade. As manufacturers navigated global restrictions, they began allocating inventory to distributors like AmerisourceBergen on a long-term basis. Additionally, we saw an increased demand for experimental treatments and products that had any semblance to supporting COVID ­patients.”

For the full article, visit Chain Drug Review